Introduction
psychotic, schizophrenia
REMISSION
Patients with schizophrenia are inclined to discontinue antipsychotics once remission is achieved for a variety of reasons [Dose-reduction was expected to be a compromise solution for this debate [While guidelines advise that patients may try to discontinue antipsychotics once they have been remitted from a first psychotic episode [The pioneering work of Wunderink Several clinical trials were initiated to test whether or not it is feasible to conduct medication reduction/discontinuation for better functioning outcomes [Currently, our GARMED trial revealed that the relapse rate of the guided dose reduction (GDR) group was not higher than their maintenance counterparts [